Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

Detalles Bibliográficos
Autores principales: Nitz, Ulrike, Gluz, Oleg, Christgen, Matthias, Kates, Ronald E., Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Lorenz-Salehi, Fatemeh, Krabisch, Petra, Just, Marianne, Augustin, Doris, Liedtke, Cornelia, Chao, Calvin, Shak, Steven, Wuerstlein, Rachel, Kreipe, Hans H., Harbeck, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491403/
https://www.ncbi.nlm.nih.gov/pubmed/30632020
http://dx.doi.org/10.1007/s10549-018-05105-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491403/
https://www.ncbi.nlm.nih.gov/pubmed/30632020
http://dx.doi.org/10.1007/s10549-018-05105-8

Ejemplares similares